2.24% Oct 17, 09:54 PM
$1.32 Paid Quarterly
30.4% EPS $4.34
2 years Since 2012
No Ex-Dividend Dates
Have Been Scheduled

DGX - Upcoming Dividend Payouts
Next Ex-Dividend Date None

Amount Declare Date Ex-Dividend Date ▲ Record Date Pay Date Payout Type
$0.3300 2014-08-15 2014-10-03 2014-10-07 2014-10-22 Regular
Date has passed
Next Ex-Dividend Date
Next Pay Date
DGX has not yet officially announced its next dividend payout.

DGX - Dividend Yield & Stock Price History
Current Dividend Yield 2.24%

Arrow-right
5y
All

DGX - Dividend Payout History
Current Annual Payout $1.32

5y
All
Dividend payouts are split-adjusted

DGX - Dividend Growth History

Annualized Growth
1994-2012
Annualized Growth
1994-2004
Annualized Growth
2004-2008
Annualized Growth
2008-2012
Annualized Growth
Last 5 Yrs
Annualized Growth
Last 3 Yrs
Annual
Growth
2012
Consecutive
Years of
Increases
Reveal Dividend Growth History for DGX. 44.2% 76.5% 2 years
Annual dividend amounts based on Ex-dividend date

DGX - Historical Annual Dividend Data & Growth
Payouts Increasing For 2 years

Payout Amount Calendar Year Annual Growth
$1.2000 2013 76.5%
$0.6800 2012 70.0%

DGX - Historical Dividend Data
Payouts Increasing For 2 years

Payout Amount Declared Date Ex-Dividend Date Record Date Pay Date ▼ Qualified Dividend? Payout Type Frequency
$0.3300 2014-08-15 2014-10-03 2014-10-07 2014-10-22 Yes Regular Quarter
$0.3300 2014-05-21 2014-07-07 2014-07-09 2014-07-23 Yes Regular Quarter
$0.3300 2014-01-30 2014-04-04 2014-04-08 2014-04-23 Yes Regular Quarter
$0.3000 2013-12-06 2014-01-03 2014-01-07 2014-01-22 Yes Regular Quarter
$0.3000 2013-08-20 2013-09-27 2013-10-01 2013-10-16 Yes Regular Quarter

Quest Diagnostics (DGX) - News

  • Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its...
  • These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Dick's Sporting...
  • Another busy day on the Street, as stocks saw some much needed relief and saw 12 companies announce increases to their dividend payouts. Aimco...
  • These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Southwest Airlines...
  • These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Visa (V) - up...
  • These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Barrick Gold...
  • Quest Diagnostics Q3 Profit Climbs, But Adjusted Net from Continuing Operations Misses Estimates (DGX)

    Before the opening bell on Thursday, diagnostic testing and services provider Quest Diagnostics Inc (DGX) reported a rise in third quarter profits, despite a decline in revenues. However, both adjusted earnings from continuing operations and revenues came up short of analysts' views. The Madison, New Jersey-based company posted a third quarter net income of $405.1 million, or $2.68 per share, up significantly from the $163.1 million, or $1.01 per share, earned in the same quarter a year ago. Quest Diagnostics' income from continuing operations came in at $402.7 million, or $2.66 per share, versus last year's third quarter income from continuing operations of $158.6 million, or 98 cents per share. On an adjusted basis, the company's net income from continuing operations was $154 million, or $1.02 per share, in the third quarter. According to analysts polled by Thomson Reuters, the company was expected to earn an adjusted $1.17 per share in the quarter. Quest Diagnostics' net revenues in the quarter edged lower to $1.79 billion from $1.82 billion in the prior year. On average, analysts were expecting the company to post revenues of $1.82 billion in the third quarter. Looking ahead to full year results, the company expects earnings from continuing operations to come in between $3.85 and $3.95 per share; previously, Quest Diagnostics had estimated earnings to be between $4.35 and $4.50 per share in fiscal 2013. Revenues are now expected to be 3.5% lower than fiscal 2012 revenues. Analysts are expecting the company to see earnings of $4.23 per share on revenues of $7.22 billion in fiscal 2013. Quest Diagnostics shares were down $1.01, or 1.72%, during morning trading on Thursday. The stock is down 1.41% year-to-date.

    The Bottom Line

    Shares of Quest Diagnostics (DGX) offer a dividend yield of 2.04% based on Wednesday's closing price of $58.74 and the company's annualized dividend payout of $1.20 per share. Quest Diagnostics Inc (DGX) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

    Expand to read the full story »

  • These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Best Buy (BBY) -...
  • Diagnostic testing, information, and services company Quest Diagnostics Inc (DGX) reported a preview of its third quarter earnings and revenues...
  • Quest Diagnostics to Acquire ConVerge Diagnostic Services (DGX)

    On Monday, diagnostic testing provider Quest Diagnostics Inc (DGX) announced that it has entered into an agreement to acquire ConVerge Diagnostic Services LLC from Water Street Healthcare Partners. ConVerge is a full-service laboratory that provides patients, physicians and hospitals with clinical, cytology and anatomic pathology testing services. DGX does not expect this purchase to affect its FY2013 EPS, but expects a modest increase in FY2014 EPS. Steve Rusckowski, President and CEO of DGX commented: "ConVerge is our fourth laboratory acquisition this year, and the second in Massachusetts, underscoring our commitment to the state and New England." "As a regional leader in women's health that is also recognized for customer service, medical expertise and innovation, ConVerge is a strong strategic fit with our business. The addition of ConVerge to the Quest family will extend the range of diagnostic information services patients and providers can access in the region while also combining the considerable medical leadership of both companies to spur new innovations that improve patient outcomes," Rusckowski added. Quest Diagnostics shares were mostly flat during pre-market trading Tuesday. The stock is up 7% YTD.

    The Bottom Line

    Shares of Quest Diagnostics Inc (DGX) have a 1.93% yield based on Monday's closing price of $62.25. Quest Diagnostics Inc (DGX) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

    Expand to read the full story »

Top-5-pitch